![](/img/cover-not-exists.png)
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study
Vici, P., Brandi, M., Giotta, F., Foggi, P., Schittulli, F., Di Lauro, L., Gebbia, N., Massidda, B., Filippelli, G., Giannarelli, D., Di Benedetto, A., Mottolese, M., Colucci, G., Lopez, M.Volume:
23
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdr412
Date:
May, 2012
File:
PDF, 196 KB
english, 2012